Cargando…

174. Treatment of Tracheitis and Antimicrobial Stewardship Interventions

BACKGROUND: Antibiotics are commonly overused in the treatment of ventilator-associated tracheitis (VAT). Antimicrobial stewardship programs (ASP) optimize antibiotic prescribing and decrease unnecessary antibiotic use. At our institution, clinicians who have initiated antibiotics for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Jennifer, Price, Michael, Yu, Diana, Newland, Jason, Jackson, Mary Anne, Weddle, Gina, Mcculloh, Russell, Myers, Angela, Day, James, Lee, Brian R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253289/
http://dx.doi.org/10.1093/ofid/ofy210.187
_version_ 1783373463849795584
author Goldman, Jennifer
Price, Michael
Yu, Diana
Newland, Jason
Jackson, Mary Anne
Weddle, Gina
Mcculloh, Russell
Myers, Angela
Day, James
Lee, Brian R
author_facet Goldman, Jennifer
Price, Michael
Yu, Diana
Newland, Jason
Jackson, Mary Anne
Weddle, Gina
Mcculloh, Russell
Myers, Angela
Day, James
Lee, Brian R
author_sort Goldman, Jennifer
collection PubMed
description BACKGROUND: Antibiotics are commonly overused in the treatment of ventilator-associated tracheitis (VAT). Antimicrobial stewardship programs (ASP) optimize antibiotic prescribing and decrease unnecessary antibiotic use. At our institution, clinicians who have initiated antibiotics for the treatment of tracheitis do not agree with ASP recommendations in 35% of cases. The goal of this study was to compare antibiotic duration and treatment failure in children treated for VAT who did and did not receive an ASP recommendation. METHODS: We performed a retrospective cohort study to evaluate VAT treatment courses and subsequent treatment failures. For this study, we included all children who were hospitalized from January 2009 to February 2013 and reviewed by ASP for receiving a monitored drug with an indication of VAT. Treatment failure was defined as a patient requiring a repeat course of antibiotics with an indication of VAT within 14 days of completing a previous antibiotic course. RESULTS: A total of 220 VAT cases were included. ASP provided recommendations to optimize antibiotics in 44 cases (20%) and stop antibiotics in 53 cases (24%). The shortest duration of treatment (days) was prescribed when ASP recommended stop therapy (median 4.7, IQR 3.0–6.5) when compared with no intervention (6.0, 4.3–7.0; P = 0.01). Treatment failure occurred in 33 (15%) cases. No difference in antibiotic duration was observed between those who did or did not fail (6.3 vs. 5.9, respectively; P = 0.11). Additionally, treatment failure rates did not differ by ASP recommendation status (no recommendation 15%; optimize 18%; stop 11%; ID involved 20%; P = 0.78). CONCLUSION: ASP recommendations for the treatment of pediatric VAT were not associated with an increased likelihood of treatment failure. Further work is needed to standardize the diagnosis and treatment of VAT to avoid unnecessary antibiotic use in these children. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253289
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62532892018-11-28 174. Treatment of Tracheitis and Antimicrobial Stewardship Interventions Goldman, Jennifer Price, Michael Yu, Diana Newland, Jason Jackson, Mary Anne Weddle, Gina Mcculloh, Russell Myers, Angela Day, James Lee, Brian R Open Forum Infect Dis Abstracts BACKGROUND: Antibiotics are commonly overused in the treatment of ventilator-associated tracheitis (VAT). Antimicrobial stewardship programs (ASP) optimize antibiotic prescribing and decrease unnecessary antibiotic use. At our institution, clinicians who have initiated antibiotics for the treatment of tracheitis do not agree with ASP recommendations in 35% of cases. The goal of this study was to compare antibiotic duration and treatment failure in children treated for VAT who did and did not receive an ASP recommendation. METHODS: We performed a retrospective cohort study to evaluate VAT treatment courses and subsequent treatment failures. For this study, we included all children who were hospitalized from January 2009 to February 2013 and reviewed by ASP for receiving a monitored drug with an indication of VAT. Treatment failure was defined as a patient requiring a repeat course of antibiotics with an indication of VAT within 14 days of completing a previous antibiotic course. RESULTS: A total of 220 VAT cases were included. ASP provided recommendations to optimize antibiotics in 44 cases (20%) and stop antibiotics in 53 cases (24%). The shortest duration of treatment (days) was prescribed when ASP recommended stop therapy (median 4.7, IQR 3.0–6.5) when compared with no intervention (6.0, 4.3–7.0; P = 0.01). Treatment failure occurred in 33 (15%) cases. No difference in antibiotic duration was observed between those who did or did not fail (6.3 vs. 5.9, respectively; P = 0.11). Additionally, treatment failure rates did not differ by ASP recommendation status (no recommendation 15%; optimize 18%; stop 11%; ID involved 20%; P = 0.78). CONCLUSION: ASP recommendations for the treatment of pediatric VAT were not associated with an increased likelihood of treatment failure. Further work is needed to standardize the diagnosis and treatment of VAT to avoid unnecessary antibiotic use in these children. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253289/ http://dx.doi.org/10.1093/ofid/ofy210.187 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Goldman, Jennifer
Price, Michael
Yu, Diana
Newland, Jason
Jackson, Mary Anne
Weddle, Gina
Mcculloh, Russell
Myers, Angela
Day, James
Lee, Brian R
174. Treatment of Tracheitis and Antimicrobial Stewardship Interventions
title 174. Treatment of Tracheitis and Antimicrobial Stewardship Interventions
title_full 174. Treatment of Tracheitis and Antimicrobial Stewardship Interventions
title_fullStr 174. Treatment of Tracheitis and Antimicrobial Stewardship Interventions
title_full_unstemmed 174. Treatment of Tracheitis and Antimicrobial Stewardship Interventions
title_short 174. Treatment of Tracheitis and Antimicrobial Stewardship Interventions
title_sort 174. treatment of tracheitis and antimicrobial stewardship interventions
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253289/
http://dx.doi.org/10.1093/ofid/ofy210.187
work_keys_str_mv AT goldmanjennifer 174treatmentoftracheitisandantimicrobialstewardshipinterventions
AT pricemichael 174treatmentoftracheitisandantimicrobialstewardshipinterventions
AT yudiana 174treatmentoftracheitisandantimicrobialstewardshipinterventions
AT newlandjason 174treatmentoftracheitisandantimicrobialstewardshipinterventions
AT jacksonmaryanne 174treatmentoftracheitisandantimicrobialstewardshipinterventions
AT weddlegina 174treatmentoftracheitisandantimicrobialstewardshipinterventions
AT mccullohrussell 174treatmentoftracheitisandantimicrobialstewardshipinterventions
AT myersangela 174treatmentoftracheitisandantimicrobialstewardshipinterventions
AT dayjames 174treatmentoftracheitisandantimicrobialstewardshipinterventions
AT leebrianr 174treatmentoftracheitisandantimicrobialstewardshipinterventions